Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Sungnam Cha CEO | KRX SM Exchange | KR7234080000 ISIN |
KR Country | - Employees | - Last Dividend | 15 May 2018 Last Split | - IPO Date |
JW Lifescience Corporation operates within the healthcare sector, focusing on the development and distribution of infusion solutions both in its home country, South Korea, and internationally. The company has carved out a niche by specializing in products vital for patient care in various medical settings. Originally established in 1994 as JW Co. Ltd., it underwent a rebranding in April 2011 to become JW Lifescience Corporation, a name that reflects its dedication to life sciences and healthcare innovations. Based in Dangjin-si, South Korea, JW Lifescience has been at the forefront of producing and supplying a range of infusion solutions, catering to diverse medical needs and contributing significantly to the field of intravenous treatment.
This foundational product category includes fluids that are essential for restoring and maintaining the body's fluid and electrolyte balance. These solutions are composed of water, electrolytes like sodium, potassium, chloride, and bicarbonate, and sometimes glucose. They are used in a wide range of medical situations, from routine hydration to emergency resuscitation.
JW Lifescience Corporation also provides nutrient-rich infusion solutions, engineered to supply vital nutrients directly into the bloodstream. These formulations typically contain amino acids, lipids, proteins, vitamins, and minerals. They are crucial for patients who are unable to eat or digest food normally, offering a method to support their nutritional needs intravenously.
The company develops and distributes specialized infusion solutions designed for specific clinical scenarios. These advanced products may be tailored to support organ function, aid in surgical recovery, or treat particular diseases or disorders. They underscore JW Lifescience Corporation's commitment to innovative healthcare solutions and their ability to meet the specialized needs of patients and medical practitioners alike.